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http://dx.doi.org/10.1016/j.pedneo.2Background: The aim of this study is to identify the association between the lipid profile
of healthy nondiabetic, nonobese pregnant women in the first weeks of the third trimester
of pregnancy and macrosomia or large-for-gestational-age (LGA) neonates with normal
pregnancies.
Materials and methods: In this cohort study, 200 pregnant healthy women without gestational
diabetes mellitus (GDM), obesity, or hypertension and carrying a single fetus in a prenatal
clinic of a referral hospital were included based on a convenience sampling. Then, we took
a blood sample to assess fasting blood sugar (FBS), triglyceride (TG), total cholesterol, low-
density lipoprotein (LDL), and high-density lipoprotein (HDL). GDM was assessed after admin-
istering 50 g of oral glucose. All cases were followed until the end of pregnancy. The main
outcome measurement was neonatal birth weight.
Results: Only 154 mothers met eligibility criteria. There were eight cases (5.2%) with macro-
somia (birth weight  4000 g) and 35 cases (22.7%) with LGA. Linear regression showed thatnd Gynecology Ward, Shahid Akbar Abadi Hospital, Iran University of Medical Sciences, Tehran, Iran.
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Maternal lipids and macrosomia 29mothers’ TG and neonates’ gender were independent predictors of the birth weight of the chil-
dren (R-square Z 0.52, p < 0.001). Logistic regression analysis showed that maternal FBS and
TG are the most independent variables which can predict the presence of macrosomia (Nagelk-
erke R-squareZ 0.53, p < 0.001) and maternal TG and child gender are the most independent
variables that can predict the presence of LGA in neonates of a healthy mother (Nagelkerke R-
square Z 0.49, p < 0.001).
Conclusion: Maternal triglyceride levels may be a significant predictor of fetal size in late preg-
nancy but not in early pregnancy. Our study reinforces that this is true not only in the case of
macrosomia (birth weight > 4500 g), but also for LGA.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Macrosomia is a common morbidity that may result in
complications for mother and neonate. Even though fetal
macrosomia occurs more often in pregnancies of diabetic
mothers, considerable numbers of infants with macrosomia
are born from nondiabetic mothers (8e14%).1 The rate of
newborns of large size in many countries is increasing.2
Diabetes is a known cause of macrosomia.3 However, 80%
of infants with macrosomia are born to mothers who do not
have hyperglycemia, and various factors have been asso-
ciated with this occurrence.4 In addition, some studies have
attempted to find a suitable index that can predict mac-
rosomia in mothers who are not diabetic,5e8 and other
studies have examined newborns of groups of mothers with
and without gestational diabetes mellitus (GDM).9e11
Clausen et al12 have assessed the risk of macrosomia in
relation to early second trimester maternal serum lipids; in
the current study, we have focused on maternal serum
lipids during the first weeks of the third trimester of preg-
nancy. This is because the possibility of developing a late
impaired glucose metabolism after the screening time in
some of the mothers could not be excluded.13
There are also known risk factors for macrosomia,
including maternal fasting glycemia, body mass index (BMI)
prior to pregnancy, and hemoglobin (Hb) A1c.3 In the cur-
rent study, we used healthy nondiabetic, nonobese, and
normotensive pregnant women to focus on the remaining
risk factors after restricting our study to such normal
mothers. Maternal factors explain approximately 50% of the
variance in birth weight, whereas paternal factors have no
significant effect.4 Growth of the fetus depends on nutri-
ents such as glucose, lipids, and amino acids.1 The
respective roles of lipids, amino acids, hormones such as
leptin, and growth factors need to be evaluated.4
Therefore, in this study we evaluated the association
between metabolic characteristics, especially lipid profile,
of the healthy nondiabetic, nonobese pregnant women in
the first weeks of the third trimester of the pregnancy and
macrosomia or large-for-gestational-age (LGA) neonates
with normal pregnancies.
2. Materials and Methods
In this cohort study, we assessed 200 pregnant women who
were referred to the prenatal clinic of the Shahid AkbarAbadi Hospital (one of the main referral hospitals in Tehran,
capital of Iran), between 2010 and 2011. All women were
generally healthy pregnant women carrying a single fetus,
between 25 weeks and 32 weeks of their gestational age,
BMI between 17.5 kg/m2 and 29 kg/m,2 without a history of
diabetes prior to or during previous pregnancies and with a
negative result from the diabetes screening test in the
current pregnancy, hypertensive disease and preeclampsia,
thyroid diseases, lupus, antiphospholipid antibody syn-
drome, and other collagen vascular diseases. Our exclusion
criteria were preterm labor prior to 37 weeks of gestational
age and any abnormality or disorder in the fetus or
neonate.
Sampling method was based on convenience method.
After including cases that met the eligibility criteria and
obtaining written informed consent, we took a blood sample
for checking fasting blood sugar (FBS), triglyceride (TG),
total cholesterol, low-density lipoprotein (LDL), and high-
density lipoprotein (HDL) after 10-12 hours of fasting. Then,
50 g oral glucose was administered for screening GDM and
serum glucose was evaluated after 1 hour. GDM was defined
as FBS higher than 90 mg/dL and 1 hour glucose tolerance
test after 50 g oral glucose higher than 130 mg/dL. Cases
with GDM or impaired glucose tolerance test (GTT) were
excluded from the study. All cases were followed until the
end of pregnancy. At this time, gestational age, complica-
tions during pregnancy, and eligibility criteria were
assessed. We gathered data about gender and birth weight
of the neonates after birth. Macrosomia was defined as
neonate birth weight higher than 4000 g. LGA was defined as
neonate’s birth weight higher than 3412 g for infants at 38
weeks of gestational age, 3622 g for infants at 39 weeks of
gestational age, 3798 g for infants at 40 weeks of gestational
age, and 3930 g for infants at 41 weeks of gestational age.
This definition was according to the neonates’ weight higher
than 75% of their predicted value according to their gesta-
tional age.14 Blood glucose wasmeasured by oxidasemethod
and lipid profiles by enzyme-linked immunosorbent assay
method. BMI was defined as kg/m2.
Statistical analysis was performed using SPSS version
20.0 (SPSS Inc., Chicago, IL, USA). Results are expressed as
mean  standard deviation (SD), minimum and maximum
value (range), and frequencies. The significance of the
differences between the study groups was tested using the
t test. Differences in categorical variables were tested
using a Chi-square test. Associations between quantitative
variables (maternal metabolic parameters and birth
Table 1 Basic characteristics of the mothers and their
neonates.
Variables Value
Mother
Demographics Age, y 26.6  5.17, 16/40
Parity 1.7  0.79, 1/4
Weight prior to
pregnancy, kg
59.7  5.76, 50/75
Height, cm 162.6  4.8,
150/170
BMI prior to
pregnancy, kg/m2
22.6  2.3,
17.7/28.6
Weight gain during
pregnancy, kg
11.6  2.69, 7/20
Gestational age at
the time of blood
sampling, wk
30  2.1, 25/32
Biochemistry FBS, mg/dL 81  5.14, 67/90
Total cholesterol,
mg/dL
201.4  38.4,
110/300
LDL, mg/dL 115.3  34.9,
38/204
HDL mg/dL, 46.6  4.36, 37/61
30 E. Mossayebi et alweight) were analyzed using Pearson correlation co-
efficients. Partial correlation was also done for eliminating
the confounder effect of other variables and determining
the main effect of the variable under study (here TG).
Stepwise linear regression analysis was performed to find
independent predictors for birth weight in the study group.
Odds ratios (ORs) and 95% confidence interval (95% CI) were
evaluated by forward stepwise logistic regression analyses.
We entered all variables with p < 0.2 in a logistic model.
Moreover, we entered variables which other studies
considered as associated with macrosomia/LGA or variables
that most studies have entered in their regression models.
Therefore, the results of our logistic models are compara-
ble with similar studies because the results are relatively
adjusted for the same confounders. A p value < 0.05 was
considered statistically significant in all statistical tests. We
also categorized quantitative variables (with significant
association with LGA) according to their quartiles. Then, we
assessed the dose-response relation of these with LGA. By
this analysis, we were seeking one criteria of Hill for
causality.
The ethics committee of the Tehran University of Medi-
cal Sciences approved the protocol of the study. All
mothers signed a written informed consent form.Total triglyceride,
mg/dL
197.5  51.9,
70/350
Child
Demographics Gender Male 72 (46.8)
Female 82 (53.2)
Birth
weight, g
Male 3476.1  413.7,
2400/4130
Female 3036.2  405.9,
2000/4100
Data are presented as mean  SD, min/max or n (%).
BMIZ body mass index; FBSZ fasting blood sugar; HDLZ high-
density lipoprotein; LDL Z low-density lipoprotein; max Z
maximum; min Z minimum; SD Z standard deviation.3. Results
In this study, 200 cases were included. There were 21 cases
(10.5%) with preterm labor prior to the 37th week of
gestational age, eight cases (4%) with hypertension during
pregnancy, one case (0.5%) of fetal death due to the
mother’s anaphylactic shock, and 16 cases (8%) with change
in address and telephone numbers that were lost to follow-
up. Basic characteristics of lost cases were not different
from the other cases. Therefore, we analyzed the results of
the 154 remaining normal mothers. Their mean age and BMI
prior to pregnancy were 26.6  5.2 years and 22.6  2.3 kg/
m2, respectively. There were eight cases (5.2%) with mac-
rosomia, 35 cases (22.7%) with LGA, and 77 cases (50%) with
nulliparity. Their FBS levels were also normal. Lipid profile
was not normal in all cases (Table 1).
Forty-six percent and 8% of neonates were male. Their
gestational age was between 38 weeks and 41 weeks, with
an average of 39.3  0.92 weeks. Birth weight of the chil-
dren was 3241.9  463.8 kg. Male children had significantly
higher birth weight (p < 0.001; Table 1). Birth weight of the
children was correlated with higher total cholesterol
(r Z 0.50, p < 0.001), LDL (r Z 0.40, p < 0.001), TG
(r Z 0.68, p < 0.001), and lower HDL (r Z 0.47,
p < 0.001) (Table 1).
Partial correlation showed when we controlled for either
total cholesterol (r Z 0.54, p < 0.001), LDL (r Z 0.60,
p < 0.001), or HDL (rZ 0.56, p < 0.001); birth weight of the
children is again correlated with TG. Stepwise linear
regression showed that mothers’ TG and neonates’ gender
were independent predictors of the birth weight of the
children (R-square Z 0.52, p < 0.001). The model shows
that 52% of the neonates’ birth weight can be predicted
according to the changes of the mothers’ TG and neonates’
gender. The model also shows that the effect of mothers’
TG during first half of the third trimester in predicting birthweight of the children is more than twofold in comparison
with neonates’ gender. Each unit increase in mothers’ TG
will increase the birth weight of the neonates by 5.24 g and
male gender will cause such increase to be 238.81 g when
the other variable is constant (Table 2).
Forward stepwise logistic regression analysis showed
that maternal FBS and TG are the most independent vari-
ables that can predict the presence of macrosomia (birth
weight  4000 g) in neonates of healthy mothers (nondia-
betic, normal BMI, without hypertension, and with term
single fetus pregnancy; Nagelkerke R-square Z 0.53,
p < 0.001). To be able to compare the importance of FBS
and triglyceride we computed their z-score and substituted
their z-score for their crude value in logistic model.
Therefore, the analysis showed that TG has a more impor-
tant role in predicting the value of a neonate’s birth weight
because z-score of maternal TG and FBS has OR (95% CI)
equal to 9.44 (2.86e31.16) and 3.09 (1.006e9.48), respec-
tively. Mothers’ TG and FBS in gestational weeks between
25 and 32 have a more important role than other variables
in predicting birth weight of the neonates. Each unit in-
crease in mothers’ FBS during the first half of the third
trimester of the pregnancy will cause a 1.24 increase in the
Table 2 Predictors of the birth weight of the neonates.
Independent variable Unstandardized coefficients Standardized
coefficients
Beta
Sig.
B SE
Triglyceride 5.24 0.54 0.59 < 0.001
Male gender of the child 238.81 56.08 0.26 < 0.001
B Z beta; SE Z standard error; Sig Z significance.
Maternal lipids and macrosomia 31odds of macrosomia of the neonate. Each unit increase in
TG will add 0.044 the odds of macrosomia of the neonate
(Table 3). We should note that if z-scores are not taken into
consideration, crude values will mislead us in ranking which
independent variable is more important. This issue was not
considered in any previously published similar studies in the
field.
Forward stepwise logistic regression analysis showed that
mother’s TG and child gender are the most independent
variables which can predict the presence of LGA (birth
weight according to gestational age as mentioned above) in
neonates of a healthy mother (Nagelkerke R- squareZ 0.49,
p< 0.001). Table 4 shows that themother’s TG in gestational
weeks between 25 and 32 and child gender have more
important roles than other variables in predicting birth
weight of the neonates. We computed the z-score of
maternal TG to be able to compare the importance of
maternal TG and neonate’s gender in predicting LGA in ne-
onates. Adjusted OR of the z-score of the maternal TG was
5.90 (95% CI: 2.68-13.00).
The mother’s age, BMI, parity, and birth (gestational)
age had no significant association with LGA. For evaluating
dose-response relation of significantly correlated variables
with LGA, we divided quantitative variables according to
their quartiles. As we can see, there was no dose- response
relationship in most variables. This may be due to our
eligibility criteria whereby we only entered cases without
significant diseases in past medical history and without
GDM, obesity, and hypertension. Only lipids and high weight
gain were associated with LGA in comparison with their
baseline characteristics, which was the lowest group in all
variables except for HDL in which the control group showed
the highest HDL level (Table 5).4. Discussion
In this study,weevaluated the role of lipid profileof pregnant
women in the first weeks of the third trimester to betterTable 3 Predictors of macrosomia in the neonates.
Independent variables * B SE of B
FBS 0.22 0.11
Triglyceride 0.04 0.01
B Z beta; CI Z confidence interval; FBS Z fasting blood sugar; OR Z
* Adjusted for mother’s age, weight prior to pregnancy, FBS, and chestimate the birth weight of neonates prior to birth. This
time of checking enabled us to check late impaired glucose
metabolism after the usual screening time in pregnant
women. Such a prediction can aid in the diagnosis of mac-
rosomia and LGA some weeks earlier than normal and can
even help to reverse the mechanism of such problems by
controlling themost independent important factor, being TG
in both linear and logistic regression models, for preventing
birth, childhood, and adulthood complications in apparently
healthy-appearing non-diabetic, nonobese, normotensive
mothers. The interesting finding was the direct effect of FBS
on macrosomia even in normal pregnancies of nondiabetic,
nonobese mothers. However, the effect of FBS was lower
than TG on macrosomia.
According to regression models, all lipids play a probable
role in birth weight via TG. Male gender is also an important
independent factor showing the inevitable role of hormonal
and genetic components. The real role of maternal hyper-
lipidemia in fetal growth is not completely understood.
However, fasting maternal TG level between 24 weeks and
32 weeks of gestation has been directly correlated with
birth weight increase at term. This effect is independent
from the effect of the mother’s obesity, weight gain during
pregnancy, and maternal FBS level during pregnancy in
various studies as well as the current one.15e17
Other studies have shown a maternal lipid level incre-
ment in the second half of gestation.11, 18e20 In women with
GDM, TG is also associated with birth weight after adjust-
ment for gestational age.21 In our study, regression models
for LGA are also adjusted for gestational age, because our
definition for LGA is according to gestational age. A similar
Indian study showed the relative risk of having heavier
babies weighing 3.5 kg or greater was 2 (95% CI: 0.9e4.2)
for women with hypertriglyceridemia and 2.6 (95% CI:
0.78e8.4) when controlled for fasting glucose, BMI, and
pregnancy weight gain. When studied together, the com-
bination of hypertriglyceridemia, fasting hyperglycemia,
and higher BMI was a significant predictor of heavier neo-
nates with RR Z 9.7 (95% CI: 1.7e62.6).20 In a study of 85Sig. Adjusted
OR
95% CI for OR
Lower Upper
0.049 1.245 1.001 1.55
< 0.001 1.044 1.02 1.07
odds ratio; SE Z standard error; Sig Z significance.
olesterol.
Table 5 Risk of LGA in relation to mothers’ metabolic and anthropometric factors’ quartiles.
Maternal factors All LGA cases, n (%) OR (95% CI) unadjusted aOR (95% CI)*
Weight prior to pregnancy
Q1: <55 36 7 (19.4) 1 1
Q2: 55e59.9 35 11 (31.4) 1.9 (0.6e5.7) 1.04 (0.27e4.1)
Q3: 60e64.9 43 10 (23.3) 1.3 (0.4e3.7) 0.53 (0.12e2.38)
Q4: 65 40 7 (17.5) 0.88 (0.28e2.8) 0.45 (0.1e2.1)
Height
Q1: <159.75 38 10 (26.3) 1 1
Q2: 159.75e162.9 35 7 (20) 0.7 (0.2e2.1) 0.84 (0.21e3.37)
Q3: 163e166.9 39 5 (12.8) 0.4 (0.1e1.3) 0.16 (0.03e0.9)
Q4: 167 42 13 (31) 1.3 (0.5e3.3) 1.1 (0.29e3.9)
Weight gain
Q1: 9 45 6 (13.3) 1 1
Q2: 9.1e11.74 32 6 (18.8) 1.5 (0.4e5.2) 1.3 (0.25e6.8)
Q3: 11.75e13 41 8 (19.5) 1.6 (0.5e5) 1.5 (0.4e6.4)
Q4:>13 36 15 (41.7) 4.6 (1.6e13.7) 4.5 (1.01e20.2)
Total cholesterol
Q1: 172 39 2 (5.1) 1 1
Q2: 172.1e199.9 35 6 (17.1) 3.8 (0.7e20.4) 2.3 (0.4e15.2)
Q3: 200e234.9 37 9 (24.3) 5.9 (1.2e29.7) 1.2 (0.2e8.6)
Q4: 235 43 18 (41.9) 13.3 (2.8e62.5) 1.1 (0.2e8.1)
LDL
Q1: 88 38 3 (7.9) 1 1
Q2: 88.1e113 40 9 (22.5) 3.4 (0.8e13.6) 2.04 (0.4e10.9)
Q3: 113.1e143.9 37 10 (27) 4.3 (1.1e17.3) 0.6 (0.1e4.03)
Q4: 144 39 13 (33.3) 5.8 (1.5e22.6) 0.8 (0.1e4.4)
HDL
Q1: 43 40 18 16.4 (3.5e77.2) 0.6 (0.07e5.3)
Q2: 43.1e46 37 10 7.4 (1.5e36.5) 0.7 (0.08e5.6)
Q3: 46.1e49.9 35 5 3.3 (0.6e18.4) 1.7 (0.2e11.6)
Q4: 50 42 2 1 1
Triglyceride
Q1:<170 37 2 (5.4) 1 1
Q2: 170e199.9 37 0 0 0
Q3: 200e229.9 37 6 (16.2) 3.4 (0.6e18) 3.2 (0.5e20.7)
Q4: 230 43 27 (62.8) 29.5 (6.2e139.6) 28.2 (3.5e230.3)
FBS
Q1: <78 35 9 (25.7) 1 1
Q2: 78e80.9 36 11 (30.6) 1.3 (0.4e3.6) 3.6 (0.8e16.3)
Q3: 81e84.9 42 5 (11.9) 0.4 (0.1e1.3) 0.5 (0.1e2.4)
Q4: 85 41 10 (24.4) 0.9 (0.3e2.6) 0.9 (0.2e3.6)
aOR Z adjusted odds ratio; CI Z confidence interval; FBS Z fasting blood sugar; HDL Z high-density lipoprotein; LDL Z low-density
lipoprotein; LGA Z large for gestational age; OR Z odds ratio; Q Z quartile.
Bold numbers show significant ORs.
* Variables in model: mother’s age, weight prior to pregnancy, FBS, triglyceride, cholesterol, and child gender. If the categorical
variable was one of these confounders or had colinearity with other variables, we excluded that variable and only the categorical
variable was entered.
Table 4 Predictors of large for gestational age in the neonates.
Independent variables * B SE of B Sig. Adjusted ORa 95% CI for OR
Lower Upper
Child male gender 1.45 0.57 0.011 4.275 1.40 13.04
Mother’s TG 0.03 0.01 < 0.001 1.035 1.02 1.05
B Z beta; CI Z confidence interval; OR Z odds ratio; SE Z standard error; Sig Z significance.
* Adjusted for mother’s age, weight prior to pregnancy, FBS, and cholesterol.
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Maternal lipids and macrosomia 33healthy mothers in Greece, children born LGA of mothers
without confirmed impaired glucose tolerance during
pregnancy (n Z 37) showed higher insulin concentrations
than children appropriate for gestational age (AGAs,
n Z 48).5 In our study, FBS was also a predictor of macro-
somia. Another similar cohort study of 2050 pregnancies in
Norway demonstrated that maternal TG in the first half of
pregnancy (early second trimester) was also associated
with a risk of macrosomia (birth weight > 4500 g).12 Many
previous studies have shown that diabetes or FBS are in-
dependent risk factors for macrosomia.1,3,6,9,12,17,19 How-
ever, few studies have focused on cases without DM,5e8 a
subgroup that has a higher proportion in comparison with
patients with diabetes or hypertension. Our target popu-
lation is these normal women.
In an Italian study on 180 pregnant Caucasian women, 83
women with normal glucose tolerance were evaluated.
Prepregnancy BMI and fasting maternal serum TG deter-
mined in the last trimester of gestation were independently
associated with neonatal birth weight in women with
normal glucose tolerance, but a positive screening test. TG
levels measured in the third trimester of pregnancy are
independent of the genetic polymorphism of ApoE.11
Another similar study in Japan on 146 women showed that
midpregnancy maternal fasting triglyceride level at 24e32
weeks (hypertriglyceridemia over 259 mg/dL) was the sig-
nificant predictor of LGA infants, independent of prepreg-
nancy BMI, maternal weight gain, and maternal plasma
glucose levels (OR Z 11.6, 95% CI: 1.1e122; p Z 0.04) ac-
cording to logistic regression analysis.22 A study on mothers
with gestational diabetes demonstrated that birth weight of
the largest offspring, maternal fasting glycemia, BMI prior to
pregnancy, HbA1c, and TG at booking were independent
predictors of a birthweight according to their strength. All of
these predictors, except TG concentrations, remained sig-
nificant when gestational age at diagnosis was entered into
models.3 A study found that triglycerides and non-HDL
cholesterol were correlated to placental weight. It is there-
fore possible that the metabolic changes associated with
maternal overweight may promote placental growth.12
Compared to the large sample or heterogeneous samples
of previous studies, we have a very homogenous sample
without diabetes, hypertension, obesity, and preterm
labor. This may be the reason that our standard deviations
are not large in most metabolic and anthropometric char-
acteristics of participants. Moreover, our relatively small
sample let us to do tests during fasting. This increases both
the validity and homogeneity of the data and decreases
type 2 error as in some other studies.12 Physicians decide
for their patients according to these standard data (fasting
values of weight, FBS, TG, and cholesterol); therefore, it
increases the practicality of the results.
The normal homogenous population in the current study
excludes discrepancies due to different diseases such as
diabetes and hypertension, and also different strategies for
treatment of such diseases and makes our sample as ho-
mogenous as possible. This may decrease the generaliz-
ability of our data to all real cases, as some of the real
cases have diseases such as diabetes and hypertension;
however, it increases the comparability of our results with
studies in which all or some proportion of their sample is
healthy pregnant women with babies of normal term.External validity (representativeness) of our data in healthy
women is high because this group of women has a very
similar definition for normal levels of blood chemistry and
has no diseases across different countries. In addition,
controlling for confounders that may distort the results
increases the homogeneity of the population under study
and representativeness of the findings. In its best situation,
our data can be reproducible only in healthy women.
A high maternal triglyceride level prior to 20 weeks of
gestation was not an independent risk factor for macrosomia
(birth weight > 4500 g) in some studies,5,12 but it was related
to birth weight in some other studies.3 However, it was inde-
pendently correlatedtobirthweightbetween24weeksand28
weeks of gestation, even after adjustment for maternal BMI22
and also obesity.23 Thus,maternal triglyceride levelsmay be a
significant predictor of fetal size in late but not in early
pregnancy. Our study reinforces that this is true not only for
macrosomia (birth weight> 4500 g) but also for LGA.
In conclusion, maternal triglyceride levels may be a
significant predictor of fetal size in late pregnancy but not
in early pregnancy.Conflicts of Interest
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